News

On Tuesday, Musk posted the results of a urine test that showed he was drug-free, with no traces of 16 substances, including amphetamines, cocaine, fentanyl, marijuana, or opioids. He followed up ...
The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative.
FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.
U.S. drug deaths dropped by roughly 40% last year among people under the age of 35. It's a welcome pivot for families and communities devastated by fentanyl.
A fire in a drug rehabilitation center in the violence-plagued Mexican state of Guanajuato killed 12 people and injured at least three others, authorities said Sunday. The fire broke out early ...
Elon Musk’s alleged drug use on the campaign trail was said to be on “a much larger and more serious scale” than previously thought, an insider has revealed. A New York Times report ...
President Donald Trump’s executive order to limit pharmaceutical prices is a mistake. To the extent that it succeeds in lowering drug costs for Americans, it will endanger the next generation of ...
U.S. President Donald Trump has launched a new effort to lower prescription drug prices for Americans that targets foreign nations — both for the lower prices they pay and the potential to ...
An executive order from President Trump aims to make deep cuts to prescription drug costs, putting GOP lawmakers who have traditionally opposed government-directed drug pricing in a tough position.… ...
Only customers will a valid M365 subscription will be able to open new cases, but three limitations will be in place once Microsoft pulls the plug on Windows 10 this October.
Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions to force lower prices.
For brand drugs in particular, U.S. prices were at least 3.2 times as high as prices in the comparison countries, even after adjustments for estimated U.S. rebates.